DGX vs PLUS · P/E 22, rev $9.87B vs P/E 17, rev $2.07B
Quest Diagnostics Incorporated (DGX) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the DGX and PLUS stock pages for the full models.
Not investment advice.